A research team in South Korea has successfully developed a novel technology that combines nanoparticles with stem cells to ...

In his PhD research at Utrecht University and UMC Utrecht, Marc Falandt developed biomaterials whose properties can be adjusted even after they have been 3D-printed, effectively adding a fourth ...

A research team in South Korea has successfully developed a novel technology that combines nanoparticles with stem cells to ...

Pluri entered strategic collaborations across Asia, Europe and the United States (“U.S.”) to transform food and agriculture production via its subsidiaries’ advanced cell expansion technologies ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development.

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the publication of a seminal manuscript in ...

A research team in South Korea has successfully developed a novel technology that combines nanoparticles with stem cells to ...

According to Nova One Advisor, the global 3D bioprinting market size is calculated at USD 2.92 billion in 2025 and is ...

ETH Zurich 3D printed human muscle in microgravity, advancing space bioprinting and biomedical research beyond Earth.

Pluri launches wholly-owned health and aesthetics subsidiary Cellav- leveraging Pluri’s proprietary 3D cell expansion platform to deliver ...